Díez-Torre Alejandro, Andrade Ricardo, Eguizábal Cristina, López Elixabete, Arluzea Jon, Silió Margarita, Aréchaga Juan
Laboratory of Stem Cells, Development and Cancer, Department of Cell Biology and Histology and Analytical and High Resolution Biomedical Microscopy Core Facility, University of the Basque Country, Leioa, Vizcaya, Spain.
Int J Dev Biol. 2009;53(8-10):1563-8. doi: 10.1387/ijdb.093021ad.
In recent years, the reversion of the cancer phenotype of human melanoma cells in developing zebrafish and chick embryos has been reported. The aim of this review is to revise these and other related contributions regarding the regulation of embryonic cancer and to provide a framework with which to understand results from our laboratory on the interactions of human melanoma cells with post-implanted mouse embryos cultured in vitro. To this end, we used the A375 human melanoma cell line transfected with the green fluorescent protein (GFP) gene. Labeled cells were transplanted onto the surface of the developing visceral endoderm of 7.5 dpc mouse embryos. Subsequently, we cultured the transplanted embryos for three days and monitored the movements of GFP labeled human melanoma cells by confocal microscopy. Our results show that ectopic melanoma cells internalize and migrate inside the embryo body in a way reminiscent of neural crest cells. The absence of localized tumor growth after 72 hours of in vitro embryo co-culture suggests that malignant phenotype inhibiting factors are active at the gastrulating stage and during early organogenesis. These results complement previous reports of growth regulation of B16 mouse melanoma cells by 10 dpc mouse embryonic skin (Gerschenson et al., 1986). Further research is required to elucidate the final fate of melanoma cells in mammalian embryos and the details of the signaling pathways underlying tumor growth regulation. Understanding regulation of melanoma cells by young embryos could represent a starting point for a developmental theory of the pathogenesis of melanoma, and for future developments of more physiologically-based anticancer therapies for this and indeed, other types of aggressive tumor.
近年来,有报道称在发育中的斑马鱼和鸡胚胎中,人类黑色素瘤细胞的癌症表型发生了逆转。本综述的目的是回顾这些以及其他有关胚胎癌症调控的相关研究,并提供一个框架,用以理解我们实验室关于人类黑色素瘤细胞与体外培养的植入后小鼠胚胎相互作用的研究结果。为此,我们使用了转染了绿色荧光蛋白(GFP)基因的A375人类黑色素瘤细胞系。将标记的细胞移植到7.5天胚龄小鼠胚胎发育中的脏内胚层表面。随后,我们将移植后的胚胎培养三天,并通过共聚焦显微镜监测绿色荧光蛋白标记的人类黑色素瘤细胞的运动。我们的结果表明,异位黑色素瘤细胞以类似于神经嵴细胞的方式内化并在胚胎体内迁移。体外胚胎共培养72小时后未出现局部肿瘤生长,这表明恶性表型抑制因子在原肠胚形成阶段和早期器官发生过程中具有活性。这些结果补充了先前关于10天胚龄小鼠胚胎皮肤对B16小鼠黑色素瘤细胞生长调控的报道(Gerschenson等人,1986年)。需要进一步研究以阐明黑色素瘤细胞在哺乳动物胚胎中的最终命运以及肿瘤生长调控潜在信号通路的细节。了解年轻胚胎对黑色素瘤细胞的调控可能是黑色素瘤发病机制发育理论的起点,也是未来针对这种以及其他类型侵袭性肿瘤开发更基于生理学的抗癌疗法的起点。